Skip to main content
Please enter a legal issue and/or a location
Begin typing to search, use arrow keys to navigate, use enter to select

Find a Lawyer

More Options

In re: Zyprexa Prods. Liab. Litig., No. 07-3815

By FindLaw Staff on February 04, 2010 | Last updated on March 21, 2019

In a drug defect product liability litigation, appellant-law firm's interlocutory appeal from the district court's order finding that all of appellant-law firm's cases that were pending in the district court were subject to certain attorney compensation strictures and that appellant was prohibited from making any disbursements from a fund that it maintained until a fund administrator had certified that the protocols had been adhered to, is dismissed where the injunction did not give or aid in giving substantive relief sought in the lawsuit, and thus there was no jurisdiction under 28 U.S.C. section 1292(a).

Read In re: Zyprexa Prods. Liab. Litig., No. 07-3815

Appellate Information

Argued: March 12, 2009

Final Submission: June 17, 2009


Per Curiam


For Appellant:

Robert J. Lack, Friedman Kaplan Seiler & Adelman LLP, New York, NY

Eric Roberson, The Mulligan Law Firm, Dallas, TX

For Appellee:

William M. Audet, Audet & Partners, LLP, San Francisco, CA

James M. Shaughnessy, Milberg LLP, New York, NY

You Don’t Have To Solve This on Your Own – Get a Lawyer’s Help

Meeting with a lawyer can help you understand your options and how to best protect your rights. Visit our attorney directory to find a lawyer near you who can help.

Or contact an attorney near you:
Copied to clipboard